BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35142286)

  • 21. Maturing neuroblastoma and ganglioneuroblastoma: a study of four cases with long survival.
    McLaughlin JE; Urich H
    J Pathol; 1977 Jan; 121(1):19-26. PubMed ID: 874625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology of neuroblastic tumors.
    Joshi VV; Silverman JF
    Semin Diagn Pathol; 1994 May; 11(2):107-17. PubMed ID: 7809504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral neuroblastomas in dogs: a case series.
    Arenas-Gamboa AM; Tanabe M; Edwards J; Storts R
    J Comp Pathol; 2014 May; 150(4):361-5. PubMed ID: 24456749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours.
    Hung YP; Lee JP; Bellizzi AM; Hornick JL
    Histopathology; 2017 Nov; 71(5):786-794. PubMed ID: 28640941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.
    Monferrer E; Burgos-Panadero R; Blanquer-Maceiras M; Cañete A; Navarro S; Noguera R
    BMC Cancer; 2019 Jan; 19(1):1. PubMed ID: 30606139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis.
    Fagone P; Nicoletti F; Vecchio GM; Parenti R; Magro G
    Acta Histochem; 2015 Oct; 117(8):820-3. PubMed ID: 26510683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.
    Lonergan GJ; Schwab CM; Suarez ES; Carlson CL
    Radiographics; 2002; 22(4):911-34. PubMed ID: 12110723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral neuroblastic tumours in eastern Denmark 1972-2002.
    Zimling ZG; Rechnitzer C; Rasmussen M; Petersen BL
    APMIS; 2007 Jan; 115(1):66-74. PubMed ID: 17223852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
    YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemical markers of neuronal maturation in human diagnostic neuropathology.
    Sarnat HB
    Cell Tissue Res; 2015 Jan; 359(1):279-94. PubMed ID: 25227552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INSM1 Expression in Peripheral Neuroblastic Tumors and Other Embryonal Neoplasms.
    Wang H; Krishnan C; Charville GW
    Pediatr Dev Pathol; 2019 Oct; 22(5):440-448. PubMed ID: 30975032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.
    Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S
    Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maturation of cerebellar neuroblastoma into ganglioneuroma with melanosis. A histologic, immunocytochemical, and ultrastructural study.
    de Chadarévian JP; Montes JL; O'Gorman AM; Freeman CR
    Cancer; 1987 Jan; 59(1):69-76. PubMed ID: 3539310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.
    Wilzén A; Krona C; Sveinbjörnsson B; Kristiansson E; Dalevi D; Øra I; De Preter K; Stallings RL; Maris J; Versteeg R; Nilsson S; Kogner P; Abel F
    Mol Cancer; 2013 Jul; 12(1):70. PubMed ID: 23835063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HuC/D expression in small round cell tumors and neuroendocrine tumors: a useful tool for distinguishing neuroblastoma from childhood small round cell tumors.
    Takemoto J; Kuda M; Kohashi K; Yamada Y; Koga Y; Kinoshita I; Souzaki R; Taguchi T; Oda Y
    Hum Pathol; 2019 Mar; 85():162-167. PubMed ID: 30468801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peripheral neuroblastic tumors: anatomo pathological classification].
    Peuchmaur M
    Ann Pathol; 2004 Dec; 24(6):556-67. PubMed ID: 15785402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from the Pediatric Oncology Group.
    Joshi VV; Silverman JF; Altshuler G; Cantor AB; Larkin EW; Neill JS; Norris HT; Shuster JJ; Holbrook CT; Hayes FA
    Hum Pathol; 1993 May; 24(5):493-504. PubMed ID: 8491489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synaptophysin: a sensitive and specific marker for ganglion cells in central nervous system neoplasms.
    Miller DC; Koslow M; Budzilovich GN; Burstein DE
    Hum Pathol; 1990 Jan; 21(1):93-8. PubMed ID: 2104823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells.
    Acosta S; Lavarino C; Paris R; Garcia I; de Torres C; Rodríguez E; Beleta H; Mora J
    BMC Dev Biol; 2009 Feb; 9():12. PubMed ID: 19216736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.